PulseAGGREGATOR

Home Feed Stories Sources Features

PulseAGGREGATOR

Gathering headlines…

Pulse Aggregator

Your news command center for 10,000+ sources. Search, filter, and set alerts — then cut through the noise with bias analysis, story clustering, and blindspot detection.

BioPharma Dive

healthCenter

2h ago

GSK wagers up to $1.3B on a different kind of cancer drugtranslating…

With its latest foray into China, GSK acquired rights from Hutchmed to an &ldquo;antibody-targeted therapy conjugate&rdquo; impacting two well-known cancer drivers, EGFR and KRAS.

Factuality

76/100

Political Bias

Center

Ownership

Industry Dive (Informa)

Country

USA

Region

North America

Language

English

Keywords#GSK#cancer#health

Read Original ↗ Article view

Comments

Loading comments…

GSK wagers up to $1.3B on a different kind of cancer drug | Pulse Aggregator